| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:1271.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Yale Center for Sleep Medicine, Yale University, New Haven, Conn.
BackgroundStroke and sleep-related breathing disorders are both common and are associated with significant morbidity and mortality. Several recent large epidemiological studies have shown a strong association between these 2 disorders independent of known risk factors for stroke. This article will outline the scientific basis for this relationship and suggest sleep-related breathing disorders as modifiable risk factors for stroke.
Summary of ReviewSeveral studies have shown a characteristic circadian rhythmicity in stroke. We have discussed the influence of normal sleep states as well as the effect of sleep-related breathing disorders on cerebral hemodynamics. The hemodynamic, metabolic, and hematologic changes during sleep-related breathing disorders in the form of decreased cerebral perfusion and increased coagulability are possible pathogenetic mechanisms for stroke. There are accumulating lines of evidence that sleep apnea disorder may indeed cause diurnal hypertension. However, the increased risk of stroke in patients with sleep-related breathing disorders appears to be independent of coexisting hypertension; the presence of hypertension would increase the risk even further. Furthermore, several studies have documented high prevalence of sleep apnea disorders in patients with transient ischemic attacks and stroke.
ConclusionsSleep-related breathing disorder appears to contribute as a risk factor for stroke through hemodynamic and hematologic changes. Because of the high prevalence of sleep apnea disorder in this population, patients with transient ischemic attacks and stroke should undergo evaluation for these disorders.
Department of Neurology, Upstate Medical University, State University of New York, Veterans Affairs Medical Center, Syracuse, New York
This article has been cited by other articles:
![]() |
P. Jennum and R. L. Riha Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing Eur. Respir. J., April 1, 2009; 33(4): 907 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cooke and J. M. Battagel A thermoplastic mandibular advancement device for the management of non-apnoeic snoring: a randomized controlled trial Eur J Orthod, August 1, 2006; 28(4): 327 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Martinez-Garcia, R. Galiano-Blancart, J.-J. Soler-Cataluna, L. Cabero-Salt, and P. Roman-Sanchez Improvement in nocturnal disordered breathing after first-ever ischemic stroke: role of Dysphagia. Chest, February 1, 2006; 129(2): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joyeux-Faure, F. Stanke-Labesque, B. Lefebvre, P. Beguin, D. Godin-Ribuot, C. Ribuot, S. H. Launois, G. Bessard, and P. Levy Chronic intermittent hypoxia increases infarction in the isolated rat heart J Appl Physiol, May 1, 2005; 98(5): 1691 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J Gibson Sleep disordered breathing and the outcome of stroke Thorax, May 1, 2004; 59(5): 361 - 363. [Full Text] [PDF] |
||||
![]() |
D Schlosshan and M W Elliott Sleep * 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome Thorax, April 1, 2004; 59(4): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. McArdle, R. L. Riha, M. Vennelle, E. L. Coleman, M. S. Dennis, C. P. Warlow, and N. J. Douglas Sleep-Disordered Breathing as a Risk Factor for Cerebrovascular Disease: A Case-Control Study in Patients With Transient Ischemic Attacks Stroke, December 1, 2003; 34(12): 2916 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kwok, D. K. K. Ng, and Y. F. Cheung BP and Arterial Distensibility in Children With Primary Snoring Chest, May 1, 2003; 123(5): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. MOHSENIN, M. T. MOSTOFI, and V. MOHSENIN The role of oral appliances in treating obstructive sleep apnea J Am Dent Assoc, April 1, 2003; 134(4): 442 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mar, J.R. Rueda, J. Duran-Cantolla, C. Schechter, and J. Chilcott The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Eur. Respir. J., March 1, 2003; 21(3): 515 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben-Shlomo and S. Melmed The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 963 - 968. [Full Text] [PDF] |
||||
![]() |
P.M. Turkington, J. Bamford, P. Wanklyn, and M.W. Elliott Prevalence and Predictors of Upper Airway Obstruction in the First 24 Hours After Acute Stroke Stroke, August 1, 2002; 33(8): 2037 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, B. Rizzato, F. Placidi, R. Baruffaldi, A. Bianconi, and M. Diomedi Carotid Artery Wall Thickness in Patients With Obstructive Sleep Apnea Syndrome Stroke, July 1, 2002; 33(7): 1782 - 1785. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |